Immix Biopharma (NASDAQ:IMMX) Receives “Buy” Rating from HC Wainwright
HC Wainwright reissued their buy rating on shares of Immix Biopharma (NASDAQ:IMMX – Free Report) in a report released on Monday morning,Benzinga reports. The brokerage currently has a $7.00 price objective on the stock. Immix Biopharma Price Performance NASDAQ IMMX opened at $1.97 on Monday. Immix Biopharma has a 1-year low of $1.26 and a […]
HC Wainwright reissued their buy rating on shares of Immix Biopharma (NASDAQ:IMMX – Free Report) in a report released on Monday morning,Benzinga reports. The brokerage currently has a $7.00 price objective on the stock. Immix Biopharma Price Performance NASDAQ IMMX opened at $1.97 on Monday. Immix Biopharma has a 1-year low of $1.26 and a […]
